Jane Street Group, LLC Exelixis, Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$21.96 - $27.6 $3.75 Million - $4.71 Million	170,800 New	170,800 $4.43 Million
Q1 2022 May 17, 2022	BUY	$17.03 - $22.67 $514,306 - $684,634	30,200 Added 20.35%	178,600 $4.05 Million
Q4 2021 Feb 15, 2022	SELL	$15.84 - $21.88 $220,176 - $304,132	-13,900 Reduced 8.56%	148,400 $2.71 Million
Q3 2021 Nov 16, 2021	BUY	$16.3 - $21.14 $321,110 - $416,458	19,700 Added 13.81%	162,300 $3.43 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $696,460 - $991,728	38,800 Added 37.38%	142,600 $2.6 Million
Q1 2021 May 18, 2021	BUY	$20.53 - $25.22 $451,660 - $554,840	22,000 Added 26.89%	103,800 $2.35 Million
Q4 2020 Feb 17, 2021	SELL	$18.39 - $24.8 $347,571 - $468,720	-18,900 Reduced 18.77%	81,800 $1.64 Million
Q3 2020 Nov 17, 2020	SELL	$20.67 - $26.94 $601,497 - $783,954	-29,100 Reduced 22.42%	100,700 $2.46 Million
Q2 2020 Aug 17, 2020	BUY	$16.46 - $27.42 $1.86 Million - $3.09 Million	112,800 Added 663.53%	129,800 $3.08 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $384,810 - $479,806	-25,400 Reduced 59.91%	17,000 $300,000
Q1 2019 May 16, 2019	SELL	$19.6 - $24.76 $664,440 - $839,364	-33,900 Reduced 44.43%	42,400 $1.01 Million
Q4 2018 Feb 15, 2019	BUY	$13.65 - $21.8 $446,355 - $712,860	32,700 Added 75.0%	76,300 $1.5 Million
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $199,962 - $282,240	12,600 Added 40.65%	43,600 $773,000
Q2 2018 Aug 15, 2018	BUY	$18.56 - $22.45 $187,456 - $226,745	10,100 Added 48.33%	31,000 $667,000
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $859,420 - $1.24 Million	-38,800 Reduced 64.99%	20,900 $463,000
Q4 2017 Feb 15, 2018	BUY	$24.23 - $30.93 $714,785 - $912,435	29,500 Added 97.68%	59,700 $1.82 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $705,170 - $883,048	30,200	30,200 $732,000

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.12 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$976 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$846 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$511 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$381 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account